These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32592111)

  • 21. Use of novel inhalation kinetic studies to refine physiologically-based pharmacokinetic models for ethanol in non-pregnant and pregnant rats.
    Martin SA; Oshiro WM; Evansky PA; Degn LL; Ledbetter AD; Ford J; Todd Krantz Q; LeFew WR; Beasley TE; El-Masri H; McLanahan ED; Boyes WK; Bushnell PJ
    Inhal Toxicol; 2014 Aug; 26(10):598-619. PubMed ID: 25144475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of medications use in pregnancy.
    Ayad M; Costantine MM
    Semin Perinatol; 2015 Nov; 39(7):508-11. PubMed ID: 26358804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models.
    Chaphekar N; Dodeja P; Shaik IH; Caritis S; Venkataramanan R
    Front Pediatr; 2021; 9():733823. PubMed ID: 34805038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
    Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
    J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models.
    Dallmann A; Pfister M; van den Anker J; Eissing T
    Clin Pharmacol Ther; 2018 Dec; 104(6):1110-1124. PubMed ID: 29633257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
    De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
    Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human experiences related to adverse drug reactions to the fetus or neonate from some maternally administered drugs.
    Shirkey HC
    Adv Exp Med Biol; 1972; 27():17-30. PubMed ID: 4140679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gestational Age-Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics.
    Anoshchenko O; Prasad B; Neradugomma NK; Wang J; Mao Q; Unadkat JD
    Drug Metab Dispos; 2020 Sep; 48(9):735-741. PubMed ID: 32591415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.
    Schalkwijk S; Buaben AO; Freriksen JJM; Colbers AP; Burger DM; Greupink R; Russel FGM
    Clin Pharmacokinet; 2018 Jun; 57(6):705-716. PubMed ID: 28744795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription drugs and pregnancy.
    Webster WS; Freeman JA
    Expert Opin Pharmacother; 2003 Jun; 4(6):949-61. PubMed ID: 12783591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation.
    Gentry PR; Covington TR; Clewell HJ
    Regul Toxicol Pharmacol; 2003 Aug; 38(1):1-16. PubMed ID: 12878049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologically-based pharmacokinetic models to predict drug exposure during pregnancy.
    Ait-Chikh C; Page G; Thoreau V
    Ann Pharm Fr; 2024 Mar; 82(2):236-242. PubMed ID: 37739215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosing dilemmas in obese children.
    Mulla H; Johnson TN
    Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologically-based pharmacokinetics of ziprasidone in pregnant women.
    Biesdorf C; Martins FS; Sy SKB; Diniz A
    Br J Clin Pharmacol; 2019 May; 85(5):914-923. PubMed ID: 30669177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Placental transfer of drugs].
    Evain-Brion D; Berveiller P; Gil S
    Therapie; 2014; 69(1):3-11. PubMed ID: 24698183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ontogeny of Drug-Metabolizing Enzymes.
    Thakur A; Parvez MM; Leeder JS; Prasad B
    Methods Mol Biol; 2021; 2342():551-593. PubMed ID: 34272706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.
    Freriksen JJM; Schalkwijk S; Colbers AP; Abduljalil K; Russel FGM; Burger DM; Greupink R
    Clin Pharmacol Ther; 2020 Jun; 107(6):1352-1361. PubMed ID: 31868223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancy.
    Chen J; You X; Wu W; Guo G; Lin R; Ke M; Huang P; Lin C
    Eur J Pharm Sci; 2023 Feb; 181():106349. PubMed ID: 36496167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.